592 related articles for article (PubMed ID: 18706916)
1. Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display.
Steiner D; Forrer P; Plückthun A
J Mol Biol; 2008 Oct; 382(5):1211-27. PubMed ID: 18706916
[TBL] [Abstract][Full Text] [Related]
2. Signal sequences directing cotranslational translocation expand the range of proteins amenable to phage display.
Steiner D; Forrer P; Stumpp MT; Plückthun A
Nat Biotechnol; 2006 Jul; 24(7):823-31. PubMed ID: 16823375
[TBL] [Abstract][Full Text] [Related]
3. Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries.
Amstutz P; Koch H; Binz HK; Deuber SA; Plückthun A
Protein Eng Des Sel; 2006 May; 19(5):219-29. PubMed ID: 16551653
[TBL] [Abstract][Full Text] [Related]
4. A designed ankyrin repeat protein evolved to picomolar affinity to Her2.
Zahnd C; Wyler E; Schwenk JM; Steiner D; Lawrence MC; McKern NM; Pecorari F; Ward CW; Joos TO; Plückthun A
J Mol Biol; 2007 Jun; 369(4):1015-28. PubMed ID: 17466328
[TBL] [Abstract][Full Text] [Related]
5. In vitro selection and characterization of DARPins and Fab fragments for the co-crystallization of membrane proteins: The Na(+)-citrate symporter CitS as an example.
Huber T; Steiner D; Röthlisberger D; Plückthun A
J Struct Biol; 2007 Aug; 159(2):206-21. PubMed ID: 17369048
[TBL] [Abstract][Full Text] [Related]
6. Designed ankyrin repeat proteins (DARPins) as novel isoform-specific intracellular inhibitors of c-Jun N-terminal kinases.
Parizek P; Kummer L; Rube P; Prinz A; Herberg FW; Plückthun A
ACS Chem Biol; 2012 Aug; 7(8):1356-66. PubMed ID: 22568706
[TBL] [Abstract][Full Text] [Related]
7. From DARPins to LoopDARPins: novel LoopDARPin design allows the selection of low picomolar binders in a single round of ribosome display.
Schilling J; Schöppe J; Plückthun A
J Mol Biol; 2014 Feb; 426(3):691-721. PubMed ID: 24513107
[TBL] [Abstract][Full Text] [Related]
8. Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells.
Spear MA; Breakefield XO; Beltzer J; Schuback D; Weissleder R; Pardo FS; Ladner R
Cancer Gene Ther; 2001 Jul; 8(7):506-11. PubMed ID: 11498772
[TBL] [Abstract][Full Text] [Related]
9. Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size.
Zahnd C; Kawe M; Stumpp MT; de Pasquale C; Tamaskovic R; Nagy-Davidescu G; Dreier B; Schibli R; Binz HK; Waibel R; Plückthun A
Cancer Res; 2010 Feb; 70(4):1595-605. PubMed ID: 20124480
[TBL] [Abstract][Full Text] [Related]
10. Efficient phage display of intracellularly folded proteins mediated by the TAT pathway.
Speck J; Arndt KM; Müller KM
Protein Eng Des Sel; 2011 Jun; 24(6):473-84. PubMed ID: 21289038
[TBL] [Abstract][Full Text] [Related]
11. Synonymous Codons and Hydrophobicity Optimization of Post-translational Signal Peptide PelB Increase Phage Display Efficiency of DARPins.
Kulmala A; Lappalainen M; Lamminmäki U; Huovinen T
ACS Synth Biol; 2022 Oct; 11(10):3174-3181. PubMed ID: 36178799
[TBL] [Abstract][Full Text] [Related]
12. DARPins: a true alternative to antibodies.
Stumpp MT; Amstutz P
Curr Opin Drug Discov Devel; 2007 Mar; 10(2):153-9. PubMed ID: 17436550
[TBL] [Abstract][Full Text] [Related]
13. DARPins as bispecific receptor antagonists analyzed for immunoglobulin E receptor blockage.
Eggel A; Baumann MJ; Amstutz P; Stadler BM; Vogel M
J Mol Biol; 2009 Oct; 393(3):598-607. PubMed ID: 19683003
[TBL] [Abstract][Full Text] [Related]
14. Designed ankyrin repeat proteins (DARPins) from research to therapy.
Tamaskovic R; Simon M; Stefan N; Schwill M; Plückthun A
Methods Enzymol; 2012; 503():101-34. PubMed ID: 22230567
[TBL] [Abstract][Full Text] [Related]
15. Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor.
Friedman M; Nordberg E; Höidén-Guthenberg I; Brismar H; Adams GP; Nilsson FY; Carlsson J; Ståhl S
Protein Eng Des Sel; 2007 Apr; 20(4):189-99. PubMed ID: 17452435
[TBL] [Abstract][Full Text] [Related]
16. SRP and Sec pathway leader peptides for antibody phage display and antibody fragment production in E. coli.
Thie H; Schirrmann T; Paschke M; Dübel S; Hust M
N Biotechnol; 2008 Jun; 25(1):49-54. PubMed ID: 18504019
[TBL] [Abstract][Full Text] [Related]
17. Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies.
Lipovsek D; Lippow SM; Hackel BJ; Gregson MW; Cheng P; Kapila A; Wittrup KD
J Mol Biol; 2007 May; 368(4):1024-41. PubMed ID: 17382960
[TBL] [Abstract][Full Text] [Related]
18. Efficient selection of IgG Fc domain-binding peptides fused to fluorescent protein using E. coli expression system and dot-blotting assay.
Jeong YJ; Kang HJ; Bae KH; Kim MG; Chung SJ
Peptides; 2010 Feb; 31(2):202-6. PubMed ID: 20025916
[TBL] [Abstract][Full Text] [Related]
19. A new generation of protein display scaffolds for molecular recognition.
Hosse RJ; Rothe A; Power BE
Protein Sci; 2006 Jan; 15(1):14-27. PubMed ID: 16373474
[TBL] [Abstract][Full Text] [Related]
20. Designed ankyrin repeat proteins as anti-idiotypic-binding molecules.
Vogel M; Keller-Gautschi E; Baumann MJ; Amstutz P; Ruf C; Kricek F; Stadler BM
Ann N Y Acad Sci; 2007 Aug; 1109():9-18. PubMed ID: 17785285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
